Press Releases

2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
DateSubject
10/31/2002 Cerus Corporation Receives Commitment for $50 Million Financing From Baxter
10/31/2002 Cerus Corporation Announces Third Quarter Results
10/24/2002 Webcast Alert: Cerus Corporation Announces Third Quarter Financial Results Conference Call
10/23/2002 Cerus Corporation Appoints Elizabeth M. Tillson, Ph.D. as Vice President, Regulatory Affairs and Quality
10/16/2002 Baxter and Cerus Announce Final European Regulatory Clearance for the First Pathogen Inactivation System for Platelets
09/26/2002 Cerus Corporation Receives $6.5 Million Award in Expanded Collaboration With the U.S. Armed Forces
07/31/2002 Cerus Corporation Announces Second Quarter Results
07/17/2002 Cerus Corporation Invites You to Join a Webcast of Its Second Quarter Conference Call.
07/11/2002 Cerus Corporation Receives $5 Million Milestone Payment From Baxter Healthcare Corporation
06/26/2002 Cerus Corporation Expands U.S. Patent Coverage for Pathogen Inactivation in Blood
06/04/2002 Cerus Invites You to a Company Update via the Web
06/04/2002 Cerus and Baxter's INTERCEPT Disposable Set for Platelets Receives European Regulatory Approval.
04/25/2002 Cerus Corporation Announces First Quarter Results
04/12/2002 Cerus Corporation Invites You to Join a Webcast of its First Quarter Conference Call
04/11/2002 Cerus Corporation Names William R. Rohn to Board of Directors
02/21/2002 Cerus and Baxter Receive FDA Concurrence to Begin Phase III INTERCEPT Red Blood Cell Trial in Chronic Indications
01/24/2002 Cerus Corporation Announces Fourth Quarter and Year End 2001 Results
01/14/2002 Cerus Corporation Invites You to Join a Webcast of Its Fourth Quarter Conference Call
01/09/2002 Cerus and Baxter Initiate Clinical Site in Pivotal Phase III Trial for INTERCEPT Red Blood Cell System

  • Global Headquarters

  • 2550 Stanwell Drive
    Concord, CA US 94520
    +1 925.288.6000

  • European Headquarters

  • Stationsstraat 79-D
    3811 MH Amersfoort, Netherlands
    +31 (0) 33 49 60 600

Email Alerts

Alerts are emailed to you when certain new company information is posted to this site.
> Sign up now!

The INTERCEPT Blood System is not approved for sale in certain countries.
  • Copyright @ 2017 Cerus Corporation. INTERCEPT, INTERCEPT Blood System and Cerus are trademarks of Cerus Corporation. InterSol and Amicus are trademarks of Fenwal, Inc.
  • Privacy
  • Legal
  • Site Map
Powered By Q4 Inc. 5.2.0.8